Skip to main content


Showing posts from 2010

Summary of U.S. New Drugs For 2010

Here is an initial list of the 2010 US new approved drugs (specifically New Molecular Entities). The way we count things, there were 19 novel newly approved drug substantces in the US last year. # USAN Tradename Icon 1 Tocilizumab Actemra / RoActemra 2 Dalfampridine Ampyra 3 Liraglutide Victoza 4 Velaglucerase alfa VPRIV 5 Carglumic acid Carbaglu 6 Polidocanol Asclera 7 Denosumab Prolia 8 Cabazitaxel Jevtana 9 Sipuleucel-T Provenge 10 Ulipristal Acetate Ella 11 Alcafatadine Lastacaft 12 Pegloticase Krystexxa 13 Fingolimod Gilenya 14 Dabigatran Etexilate Pradaxa 15 Lurasidone Latuda 16 Ceftaroline Fosamil Teflaro 17 Eribulin Mesylate Halaven 18 Tesamorelin Egrifta 19 Dienogest Natazia 12 are small molecule drugs, and 7 are biologicals. Of the small molecule drugs, 6 (32%) are small molecule synthetic drugs , 6 (32%) are small molecule natural product-derived drugs , 6 (32%) are biologicals (including pepti

A local meeting for local people

Andreas Bender from the Unilever Center in Cambridge has set up a series of meetings for networking of molecular modellers, chemoinformaticians and allied trades  for the Cambridge, UK, area. The meetings alternate between the University in Cambridge and the EBI, these have been great fun so far, and there is now a web-site  for the Cambridge Cheminformatic Network, with a Doodle Poll for dates for the 2011 meetings.

UK Research Council Science Funding 2011-2015

Today, RCUK and The UK research councils a nnounced the budgets and priorities for UK science spending for 2011-2015. A link to the BBSRC delivery plan is here .

Links to ChEMBL data from Wikipedia

Everyone's favorite free encyclopedia - wikipedia , has started to get links to ChEMBL added. The links are all sorted out, now we just need a bot to go round and sort everything out for a large set of compounds. So, to give you some idea of how it will look, here are some links to some classics Sildenafil Paracetamol Imatinib So, do you think it is worth adding links for targets as well as compounds ?

ChEMBL now has a Japanese language Wikipedia page

ChEMBL ( ケンブル ) is now on Japanese  Wikipedia . Note, the page is currently flagged as spam, so hopefully this will change when it is reviewed....

ChEMBL Bioactivity Course February 2011 - Registration Open

Registration for the 2011 residential ChEMBL Training course, running from the 14th to the 18th of Feburary 2011, is now underway, further details can be found at this  link . What better way to spend  Valentine's Day ?

ARMC Vol 45 is out!

One of the highlights of the year for me is the gentle thud of ARMC (Annual Reviews in Medicinal Chemistry) landing in my pigeon hole at work. This book alone, I consider, justifies my ACS membership dues. Volume 45 is edited by John Macor, and has some excellent chapters, highlights for me were the TLR review, the epigenetic targets, the neglected tropical diseases and the drug attrition chapters. Lots and lots to keep you occupied on your commute (unless you drive). %J Annu Rev. Med. Chem. %V 45 %E J.E. Macor %I Academic Press %O ISBN 978-0-12-380902-5 %O ISSN 0065-7743

A conference goers bag of drugs?

I was musing on the drugs I need to take with me while travelling. Here is the first go at a list. This trip, I packed only one item..... DEET (for pesky insects that love your blood even more you do - thanks Dr. Congreve! ). Aspirin (for the inevitable headache, fever and as a bonus an anticoagulant for flights, especially in economy seats - one of Nature's true gifts - aspirin that is, not economy class seats). Paracetamol (headache from sporadic/atypical alcohol consumption). Loperamide (disturbed digestive habits, fluid loss). Azithromycin (just in case of serious life threatening infections, often difficult to get abroad, use responsibly - thanks Dr. Schoichet! ). Loratidine (anti-histamine, insect bites, bed-bugs, allergies, etc ). Diphenhydramine (a sedative anti-histamine for disturbed sleep patterns, or to block out the presence of your annoying fidgety neighbour on the plane). Ranitidine (for inevitable over-indulgence and subsequent disturbed digestion

Update of Chemistry Follow-up on GSK Malaria HTS set

Here is an update on some follow-on chemistry on the GSK Malaria screening set , provided by the researchers at GSK's Tres Cantos Medicines Development Campus . Chemistry in progress TCMDC-123822, TCMDC-123823, TCMDC-123824, TCMDC-123827, TCMDC-134513, TCMDC-123579, TCMDC-123582, TCMDC-125454, TCMDC-134141, TCMDC-134142, TCMDC-134143, TCMDC-134692, TCMDC-135254, TCMDC-135271, TCMDC-135426, TCMDC-135461, TCMDC-135462, TCMDC-135463, TCMDC-135554, TCMDC-135654, TCMDC-135655, TCMDC-135656, TCMDC-135657, TCMDC-135677, TCMDC-135687, TCMDC-135789, TCMDC-135796, TCMDC-135816, TCMDC-135911, TCMDC-136013, TCMDC-136014, TCMDC-136015, TCMDC-136016, TCMDC-136051, TCMDC-136060, TCMDC-136134, TCMDC-136185, TCMDC-136188, TCMDC-136303, TCMDC-139046 Chemistry on hold TCMDC-123540, TCMDC-123620, TCMDC-123685, TCMDC-123755, TCMDC-123796, TCMDC-123825, TCMDC-124434, TCMDC-124501, TCMDC-125331, TCMDC-125334, TCMDC-125650, TCMDC-134557, TCMDC-134672, TCMDC-134674, TCMDC-134675, TCMDC-135196, TC

canSAR v1.0 launched

Yesterday, Cancer Research UK press released the launch of the first full version of canSAR - the Institute of Cancer Research's integrated cancer research and drug discovery resource. canSAR integrates large volumes of disparate data covering most aspects of cancer biology and chemistry, and is an example of how to complement the chEMBL database with therapeutic area specific knowledge. canSAR integrates biological annotation, gene expression, RNA interference studies, structural biology and protein interaction network data - as well as chemical and pharmacological data. It contains annotation on the entire human proteome, and contains >8 million experimental data points including RNAi and chemical screening data. For full release notes please see canSAR news . canSAR is updated monthly. As well as the wonderful chEMBL, the data in canSAR comes from a large number of sources, including ArrayExpress , PDBe , ROCK , STRING , Genomics of Drug Sensitivity in Cancer , COSM

Any old unwanted SGI dial boxes?

I am doing a surprising amount of molecular graphics stuff at the moment, and have finally realised I don't have the skills or coordination to use a mouse/keyboard to do simple rotations/scaling/clipping etc. So, it turns out it's possible to connect up a dial box to a aMacBook Pro, with a little bit of messing around with drivers. So does anyone have an old, unwanted dial box for an SGI machine? Part numbers  9980991,  9980992, and  9780804 are all apparently OK. If you have one of these, let me know .

2010 New Drug Approvals - Pt. XVIII - Tesamorelin (Egrifta)

ATC code (partial): H01AC Also this month, on November 10th, FDA has approved Tesamorelin under the trade name Egrifta. Tesamorelin (research code:TH-9507) is an analog of the human growth hormone-releasing factor (GRF)  (UniProt: P01286 , synonym:Somatoliberin, synonym:GRF, synonym:GHRH) indicated for the reduction of excess abdominal fat in HIV -infected patients with lipodystrophy . Lipodystrophy is a condition in which excess fat develops in atypical areas of the body, most notably around the liver, stomach, and other abdominal organs. This condition is observed as a side effect with many antiretroviral drugs used to treat HIV. Tesamorelin is the first-FDA approved treatment specifically approved for lipodystropy. The -relin INN stem covers prehormones or hormone releasing peptides, a very broad range of targets and pharmacology. The -morelin stem sub-group covers growth hormone-release stimulating peptides including capromorelin, dumorelin, examorelin, ipamorelin, pralmorel

Domain-level annotation of binding-sites for ligands within ChEMBL

One big problem of simple sequence searching with tools like blast  with ChEMBL is the problem of the introduction of contextually incorrect target relationships due to matching of irrelevant domains. For example, imagine a protein, X , that contains two domains of types A and B , and a second protein, Y , which contains also two domain types, B and C . If the ligand is known to bind to domain type A , there is no ligand-binding relationship between X and Y ; however, if the ligand binds at domain type B in X , then there is a relevant relationship between X and Y . This may sound like an rare example, but it is surprisingly common (and extremely annoying), since the majority of eukaryotic proteins are multi-domain, and the presence of certain domains, such as an EGF-like domain (Pfam: pf00009 ) can greatly complicate the analysis of sequence searches. What is really needed is a reliable mapping (or more generally a probabilistic score) of the ligand-binding domains within a parti

What Are The Key Clinical Candidate Disclosure Meetings?

Here is a call for assistance, all input will end up published on The ChEMBL-og , and accessible to one-and-all. What we're looking for is a pretty comprehensive list of key clinical candidate disclosure meetings, ideally those with disclosure of chemical structure, functional assay, pharmacokinetic and toxicology data - you know the sort of meeting, where the key data on a hot compound is disclosed for the first time. I've put together a preliminary list here , from memory and a little bit of googling - this is far, far, far from perfect and is woefully incomplete, and am now looking for addition of extra meetings for the areas not covered, and some highlighting of additional ones. As you will see I've used the ATC classification for the structure of the list - although this is not perfect for things like anti-microbials, etc., it is actually a pretty good framework to hang this off. If you have any suggestions, please mail them in .... Finally, if you are intereste

2010 New Drug Approvals - Pt. XVII- Eribulin Mesylate (Halaven)

ATC code (partial): L01C On November 15th, 2010, the FDA approved Eribulin Mesylate (ResearchCode:E-7389) under the trade name Halaven (TradeMark: Halaven ). It is indicated for for the treatment of patients with late stage, metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Phase III trials showed that patients survived a median of 2.5 months longer than patients treated with other current alternatives. Eribuln is a synthethic analogue of halichondrin B , a cytotoxic polyether macrolide marine natural product. The mechanism of action of Eribulin is anti-mitotic and is mediated via tubulin binding, where it leads to G2/M block in the the cell-cycle ; after prolonged stalling in this state, cells enter apoptosis and are then cleared. Eribulin is a large (Mwt 729.9 for Eribulin and 826.0 for the mesylate salt) synthetic compound (an analogue of halichondrin B) an IUPAC name of the struc

ChEMBL_08 Released

We are pleased to announce the release of chembl_08. This version of the ChEMBL database was prepared 26th October 2010 and contains: 735393 compound records 636269 compounds (of which 635933 have molfiles) 488898 assays 2973034 activities 8088 targets 38462 publications 5 activity data sources You can also download the ChEMBL database (Oracle 9i, 10g, 11g or MySQL) from our ftp site: . Changes to the database (please see release notes for more detail): FDA approved drugs have now been added to the compounds table*. Some drugs (e.g., biotherapeutics) do not have a structure/molfile, and not all drugs have bioactivity data associated with them. Further information for these drugs (e.g., mechanism of action) will be added in subsequent releases. Parent compounds have been generated by removing the salt component from any compounds tested as a salt form. Both the parents and the salt forms are recorded in the compounds

SMR Meeting - Trends in Medicinal Chemistry - 9th December 2010

The next Society for Medicines Research meeting is on the 9th December 2010 at the National Heart and Lung Institute , Kensington, London. These are my favourite day meetings, cheap, well organised and very applied to actual drug discovery. This meeting there are some great talks. Unfortunately, I cannot go to the SMR meeting - I will be ill (probably), in a hotel (hopefully), maybe on the beach (certainly) at the Zing Structural Biology Conference.  The graph above answered an important question for me.

2010 New Drug Approvals - Pt. XVI - Ceftaroline Fosamil (Teflaro)

ATC code (partial): J01DI On October 29th, FDA has approved Ceftaroline Fosamil under the trade name Teflaro. Ceftaroline Fosamil (previously known by the research code TAK-599, the parent drug, Ceftaroline is also known as T-91,825) is an antibiotic indicated for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive and Gram-negative microorganisms, such as Staphylococcus aureus (including methicillin-susceptible and -resistant isolates), Streptococcus pyogenes , Streptococcus agalactiae , Escherichia coli , Klebsiella pneumoniae , and Klebsiella oxytoca , and also for the treatment of community-acquired bacterial pneumonia (CABP) caused by susceptible Gram-positive and Gram-negative bacteria, such as Streptococcus pneumoniae (including cases with concurrent bacteremia ), Staphylococcus aureus (methicillin-susceptible isolates only), Haemophilus influenzae , Klebsiella pneumoniae , Klebsiella oxytoca , an

Small Molecules Bioactivity Course - February 2011

Registration for the 2011 residential ChEMBL Training course, running from the 14th to the 18th of Feburary, is now underway, further details can be found at this link . What better way to spend Valentine's Day ? The picture above is of the ingredients in a Twinkie , apparently.

Staff Position in ChEMBL - EU-OPENSCREEN database developer

The EBI recruitment website now has the EU-OPENSCREEN developer position detailed. Closing date is the 12th December 2010 . The job is an exciting opportunity to work on establishing a pan European archive of academic screening data.